David Berman

Biography

Dr. David Berman has been Senior Vice President & Head of Oncology Innovative Medicines at MedImmune, LLC. since 2015. Mr. Berman served as Vice President and Head of the Immuno-oncology Exploratory Development Team at Bristol-Myers Squibb since 2013 until 2015. He served as Executive Director of Global Clinical Lead for Ipilimumab (YERVOY) at Bristol-Myers Squibb since 2011 until 2013. He served as Group Director of Global Clinical Lead for Elotuzumab at Bristol-Myers Squibb since 2008 until 2011. He served as Director of Oncology Discovery Medicine at Bristol-Myers Squibb since 2005 until 2008. He is Fellowship from The Johns Hopkins Hospital. He is Residency Anatomic Pathology from National Cancer Institute. Mr. Berman holds MD and PhD from The University of Texas Southwestern Medical Center at Dallas. 

Research Interest

Anatomic Pathology